NDSIB
RMD icon

North Dakota State Investment Board’s ResMed RMD Stock Holding History

North Dakota State Investment Board’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$846K Buy
4,341
+121
+3% +$25.1K 0.03% 366
2026
Q1 		$947K Sell
4,220
-786
-16% -$196K 0.04% 318
2025
Q4 		$1.21M Buy
+5,006
New +$1.28M 0.04% 313

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

North Dakota State Investment Board's RMD Position: Q2 2026 in Review

North Dakota State Investment Board increased its ResMed (RMD) stake by 2.9% in Q2 2026, buying an estimated $25.1K and bringing the position to 4,341 shares worth $846K. The position accounts for 0.03% of the portfolio, ranked #366.

North Dakota State Investment Board first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.21M in Q4 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • North Dakota State Investment Board held 4,341 shares of ResMed worth $846K as of Q2 2026.
  • North Dakota State Investment Board bought 121 ResMed shares in Q2 2026, an estimated $25.1K.
  • ResMed made up 0.03% of North Dakota State Investment Board's portfolio in Q2 2026, its #366 holding.
  • North Dakota State Investment Board first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's ResMed position peaked at $1.21M in Q4 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.